Comabella, Manuel <br/><br/>
Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.  [electronic resource] 

 -  Journal of neurology  Aug 2008 
 - 1136-41 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0340-5354 
<br/><br/><label>Standard No.: </label>10.1007/s00415-008-0855-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adult<br/>Analysis of Variance<br/>Double-Blind Method<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--blood<br/>Interferon beta-1b<br/>Interferon-beta--therapeutic use<br/>Interleukin 1 Receptor Antagonist Protein--blood<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Chronic Progressive--blood<br/>Receptors, Tumor Necrosis Factor--blood<br/>Statistics as Topic<br/>Time Factors